{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:16:53Z","timestamp":1785554213876,"version":"3.56.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for Central Universities of the Central South University","doi-asserted-by":"publisher","award":["DUT21RC(3)057"],"award-info":[{"award-number":["DUT21RC(3)057"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603182"],"award-info":[{"award-number":["81603182"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703607"],"award-info":[{"award-number":["81703607"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jpba.2022.114751","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T02:06:09Z","timestamp":1649124369000},"page":"114751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Ultrafast and high-throughput quantitative analysis of carbamazepine in human plasma by direct analysis in real time tandem mass spectrometry coupled with solid phase extraction to eliminate matrix effects"],"prefix":"10.1016","volume":"214","author":[{"given":"Meiyun","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujian","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.jpba.2022.114751_bib1","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1080\/14656566.2020.1770729","article-title":"What place do carbamazepine-related antiepileptic drugs have in the modern day treatment of epilepsy?","volume":"21","author":"Lattanzi","year":"2020","journal-title":"Expert Opin. Pharmacother."},{"issue":"7","key":"10.1016\/j.jpba.2022.114751_bib2","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1517\/14656566.2016.1168399","article-title":"Carbamazepine-related antiepileptic drugs for the treatment of epilepsy \u2013 a comparative review","volume":"17","author":"Gierbolini","year":"2016","journal-title":"Expert Opin. Pharmacother."},{"issue":"4","key":"10.1016\/j.jpba.2022.114751_bib3","first-page":"200","article-title":"Treatment of epilepsy with carbamazepine","volume":"82","author":"Elian","year":"1972","journal-title":"Harefuah"},{"issue":"26","key":"10.1016\/j.jpba.2022.114751_bib4","first-page":"1263","article-title":"Carbamazepine in the treatment of epilepsy","volume":"56","author":"Poch","year":"1969","journal-title":"Prensa Med. Argent."},{"issue":"21","key":"10.1016\/j.jpba.2022.114751_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/dtb.5.21.83","article-title":"Carbamazepine for epilepsy","volume":"5","author":"BPG Ltd","year":"1967","journal-title":"Drug Ther. Bull."},{"issue":"7605","key":"10.1016\/j.jpba.2022.114751_bib6","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/bmj.39022.436389.BE","article-title":"Side effects of phenobarbital and carbamazepine in childhood epilepsy: randomised controlled trial","volume":"334","author":"Banu","year":"2007","journal-title":"Bmj"},{"issue":"5","key":"10.1016\/j.jpba.2022.114751_bib7","first-page":"196","article-title":"Increased risk of side-effects in psychiatric patients treated with clozapine and carbamazepine: a reanalysis","volume":"33","author":"Langbehn","year":"2000","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"10.1016\/j.jpba.2022.114751_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0924-977X(97)00406-9","article-title":"Side effects from increased doses of carbamazepine on neuropsychological and posturographic parameters of humans","volume":"7","author":"Delcker","year":"1997","journal-title":"Eur. Neuropsychopharm."},{"issue":"44","key":"10.1016\/j.jpba.2022.114751_bib9","first-page":"2265","article-title":"Generalized side effects with the use of carbamazepine","volume":"139","author":"Tijhuis","year":"1995","journal-title":"Ned. Tijdschr. voor Geneeskd."},{"issue":"6","key":"10.1016\/j.jpba.2022.114751_bib10","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1528-1157.1988.tb04237.x","article-title":"Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy in children","volume":"29","author":"Herranz","year":"1988","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.jpba.2022.114751_bib11","first-page":"615","article-title":"The side-effects of carbamazepine","volume":"62","author":"Gayford","year":"1969","journal-title":"Proc. R. Soc. Med."},{"issue":"3","key":"10.1016\/j.jpba.2022.114751_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0030-4220(68)90399-X","article-title":"The side effects of carbamazepine therapy","volume":"26","author":"Redpath","year":"1968","journal-title":"Oral Surg. Oral Med. Oral. Pathol."},{"issue":"22","key":"10.1016\/j.jpba.2022.114751_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10225396","article-title":"Therapeutic drug monitoring of carbamazepine: a 20-year observational study","volume":"10","author":"Grzesk","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jpba.2022.114751_bib14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jpba.2015.02.045","article-title":"Therapeutic drug monitoring of carbamazepine and its metabolite in children from dried blood spots using liquid chromatography and tandem mass spectrometry","volume":"109","author":"Shokry","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"5","key":"10.1016\/j.jpba.2022.114751_bib15","first-page":"415","article-title":"Investigation on the therapeutic effect of carbamazepine on the mood disorders in Japan","volume":"107","author":"Okuma","year":"2005","journal-title":"Seishin shinkeigaku zasshi\u2009=\u2009Psychiatr. Neurol. Jpn."},{"key":"10.1016\/j.jpba.2022.114751_bib16","first-page":"1112","article-title":"Therapeutic drug monitoring of carbamazepine","volume":"48 Suppl.","author":"Gomita","year":"1990","journal-title":"Nihon rinsho Jpn. J. Clin. Med."},{"key":"10.1016\/j.jpba.2022.114751_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2013.02.026","volume":"925","author":"Serralheiro","year":"2013","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2022.114751_bib18","doi-asserted-by":"crossref","unstructured":"H.A. Mowafy, F.K. Alanazi, G.M. El Maghraby, Development and validation of an HPLC-UV method for the quantification of carbamazepine in rabbit plasma, Saudi Pharm. J.: SPJ: Off. Publ. Saudi Pharm. Soc., vol. 20(1), 2012, pp. 29\u201334.","DOI":"10.1016\/j.jsps.2011.04.003"},{"issue":"12","key":"10.1016\/j.jpba.2022.114751_bib19","first-page":"591","article-title":"Quantitative determination of carbamazepine in tablets by reverse phase HPLC","volume":"123","author":"Mamolo","year":"1984","journal-title":"Boll. Chim. Farm."},{"issue":"27","key":"10.1016\/j.jpba.2022.114751_bib20","first-page":"1651","article-title":"Immuno-allergic side effects induced by the administration of carbamazepine. Case contribution","volume":"75","author":"Paladini","year":"1984","journal-title":"Minerva Med."},{"issue":"4","key":"10.1016\/j.jpba.2022.114751_bib21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1469-8749.1979.tb01647.x","article-title":"Carbamazepine serum levels in children with epilepsy: a micro immuno-assay technique","volume":"21","author":"Forsythe","year":"1979","journal-title":"Dev. Med. Child Neurol."},{"issue":"11","key":"10.1016\/j.jpba.2022.114751_bib22","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.chemosphere.2011.04.072","article-title":"Application of an ELISA to the quantification of carbamazepine in ground, surface and wastewaters and validation with LC-MS\/MS","volume":"84","author":"Calisto","year":"2011","journal-title":"Chemosphere"},{"key":"10.1016\/j.jpba.2022.114751_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cca.2017.07.013","article-title":"An LC-MS\/MS based candidate reference method for the quantification of carbamazepine in human serum","volume":"472","author":"Taibon","year":"2017","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"issue":"16","key":"10.1016\/j.jpba.2022.114751_bib24","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.4155\/bio.15.99","article-title":"A LC-MS\/MS method for therapeutic drug monitoring of carbamazepine, lamotrigine and valproic acid in DBS","volume":"7","author":"Linder","year":"2015","journal-title":"Bioanalysis"},{"issue":"8","key":"10.1016\/j.jpba.2022.114751_bib25","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1248\/bpb.b15-00191","article-title":"Validation of an LC-MS\/MS method for the determination of propofol, midazolam, and carbamazepine in rat plasma: application to monitor their concentrations following co-administration","volume":"38","author":"El Hamd","year":"2015","journal-title":"Biol. Pharm. Bull."},{"issue":"20","key":"10.1016\/j.jpba.2022.114751_bib26","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1007\/s00216-019-01891-2","article-title":"Ultrahigh-throughput absolute quantitative analysis of linezolid in human plasma by direct analysis in real time mass spectrometry without chromatographic separation and its application to a pharmacokinetic study","volume":"411","author":"Yin","year":"2019","journal-title":"Anal. Bioanal. Chem."},{"issue":"Pt 2","key":"10.1016\/j.jpba.2022.114751_bib27","article-title":"Rapid differentiation and quality control of tobacco products using direct analysis in real time mass spectrometry and liquid chromatography mass spectrometry","volume":"238","author":"Losso","year":"2022","journal-title":"Talanta"},{"issue":"6","key":"10.1016\/j.jpba.2022.114751_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.9013","article-title":"Applications of direct analysis in real time mass spectrometry in food analysis: a review","volume":"35","author":"Zhang","year":"2021","journal-title":"Rapid Commun. Mass Spectrom.: RCM"},{"issue":"Suppl. 2","key":"10.1016\/j.jpba.2022.114751_bib29","article-title":"Rapid identification of polyamides using direct analysis in real time mass spectrometry","volume":"34","author":"Abe","year":"2020","journal-title":"Rapid Commun. Mass Spectrom.: RCM"},{"issue":"5","key":"10.1016\/j.jpba.2022.114751_bib30","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1021\/acs.analchem.7b04060","article-title":"High-throughput analysis for artemisinins with deep eutectic solvents mechanochemical extraction and direct analysis in real time mass spectrometry","volume":"90","author":"Wang","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2022.114751_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.121095","article-title":"Rapid and high-throughput screening of multi-residue pharmaceutical drugs in bovine tissue using solid phase microextraction and direct analysis in real time-tandem mass spectrometry (SPME-DART-MS\/MS)","volume":"217","author":"Khaled","year":"2020","journal-title":"Talanta"},{"issue":"12","key":"10.1016\/j.jpba.2022.114751_bib32","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1080\/02652030903232753","article-title":"Assessing direct analysis in real-time-mass spectrometry (DART-MS) for the rapid identification of additives in food packaging","volume":"26","author":"Ackerman","year":"2009","journal-title":"Food Addit. Contam. A"},{"issue":"26","key":"10.1016\/j.jpba.2022.114751_bib33","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1007\/s00216-017-0553-x","article-title":"Screening of additives and other chemicals in polyurethanes by direct analysis in real time mass spectrometry (DART-MS)","volume":"409","author":"Kuki","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2022.114751_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2021.114435","article-title":"High-throughput and trace analysis of diazepam in plasma using DART-MS\/MS and its pharmacokinetic application","volume":"635","author":"Liu","year":"2021","journal-title":"Anal. Biochem."},{"issue":"20","key":"10.1016\/j.jpba.2022.114751_bib35","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1007\/s00216-019-01891-2","article-title":"Ultrahigh-throughput absolute quantitative analysis of linezolid in human plasma by direct analysis in real time mass spectrometry without chromatographic separation and its application to a pharmacokinetic study","volume":"411","author":"Yin","year":"2019","journal-title":"Anal. Bioanal. Chem."},{"issue":"1","key":"10.1016\/j.jpba.2022.114751_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72490-w","article-title":"Direct analysis in real time-mass spectrometry for rapid quantification of five anti-arrhythmic drugs in human serum: application to therapeutic drug monitoring","volume":"10","author":"Gui","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpba.2022.114751_bib37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jpba.2018.12.030","article-title":"Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse?","volume":"165","author":"Kaza","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2022.114751_bib38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jchromb.2018.07.005","article-title":"Bioanalytical method validation of endogenous substances according to guidelines by the FDA and other organizations: basic need to specify concentration ranges","volume":"1093\u20131094","author":"Tsikas","year":"2018","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"4","key":"10.1016\/j.jpba.2022.114751_bib39","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4155\/bio.13.329","article-title":"Common bioanalytical deficiencies with bioequivalence submissions in abbreviated new drug applications","volume":"6","author":"Williamson","year":"2014","journal-title":"Bioanalysis"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522001728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522001728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:22:12Z","timestamp":1760001732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708522001728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":39,"alternative-id":["S0731708522001728"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2022.114751","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ultrafast and high-throughput quantitative analysis of carbamazepine in human plasma by direct analysis in real time tandem mass spectrometry coupled with solid phase extraction to eliminate matrix effects","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2022.114751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114751"}}